Atogepant

Educational summary, not a formulary. Dosing is quoted from the Makindo chapters and topics site. The other sections are draft summaries not yet checked line by line against the BNF or SPC. Check dose, indication, interactions and monitoring in the BNF entry for Atogepant and local guidelines before prescribing.

CGRP antagonist

Mechanism

Oral CGRP receptor antagonist.

Uses

Migraine prophylaxis.

Dosing

No dose is given in the chapters. See the BNF.

Side effects

Nausea, constipation, fatigue.

Interactions

Strong CYP3A4 inhibitors raise levels.

Contraindications and cautions

Severe hepatic impairment

Monitoring

Migraine diary

Pregnancy and breastfeeding

Avoid

Renal and hepatic impairment

Avoid in severe hepatic impairment

Overdose and reversal

Supportive

Special advice

Dose-reduce with interactions.

More from the textbook: uses, cautions and other points
Where it is discussed in the book